Mobile Menu

Genomics week in brief: Week ending 24th June

Check out the latest Genomics Week in Brief – full of intriguing news and research from the genomics space!

Top stories from the past week

  • Rare germline deleterious variants have been found to increase susceptibility for lung cancer. (Sang et al)
  • Researchers investigated DNA methylation as a mediator of genetic risk in childhood acute lymphoblastic leukaemia. (Xu et al)
  • University of Pennsylvania researchers demonstrated that embryo cryopreservation leads to sex-specific DNA methylation perturbations in human placentas. (Mani et al)
  • Scientists demonstrated that alternative splicing plays a critical role in the formation and growth of paediatric cancers. (Venkataramany et al)
  • A new study summarises the evolutionary genetic variation in type 1 diabetes and the racial and ethnic differences in type 1 diabetes epidemiology, clinical characteristics, and preclinical course. (Redondo et al)
  • Researchers caution the use of cellular tests to detect Lyme Borreliosis. (Theel et al)
  • A large-scale retrospective study demonstrated that the combination of serum markers and endoscopic findings was essential for the risk evaluation of gastric cancer. (Nagasaki et al)
  • PDZK1 interacting protein 1 (PDZK1IP1) was identified as promoting the progression of papillary thyroid cancer. (Wang et al)
  • Researchers demonstrated the use of exome sequencing as a tool for detecting point mutations and deletions in patients with hypogonadotropic hypogonadism. (Young et al)
  • An international team proposed a new procedure to measure pairwise nonlinear correlations with applications for gene expression data. (Tripathi et al)
  • Researchers demonstrated a high throughput SARS-CoV-2 variant analysis using molecular barcodes coupled with next generation sequencing. (Cohen-Aharonov et al)
  • Single-cell analyses highlighted the proinflammatory contribution of C1q-high monocytes to Behçet’s disease. (Zheng et al)
  • Researchers have discovered new molecular signatures that may help predict the long-term risk of liver cancer in patients with nonalcoholic fatty liver disease. (Fujiwara et al)
  • Researchers discovered a bacterium that challenges the prevailing view of bacterial cell size – it is visible to the naked eye. (Volland et al)

In other news:

  • Many researchers say they’ll share data – but don’t. (Nature)
  • Experts believe a new form of photoimmunotherapy may become the fifth major cancer treatment (Guardian)
  • America’s first CRISPR trials is still nearly 100% effective 3 years on. (New Atlas)
  • People in Wales affected by mental health issues will be able to benefit from a new genetics service. (BBC News)
  • A new technique leads to kids to having kidney transplants without immune suppression. (Science Alert)
  • An MIT-led team has built a new computer model that can rapidly scan the entire genome of cancer cells and identify mutations that drive tumour growth. (MIT News)
  • Drug cocktail makes stem cells that could grow organisms from scratch. (New Atlas)

Image credit: canva

More on these topics

Cancer / Gene Editing / Genomics / Week in brief